Liver Steatosis

Patient presents with suspected nonalcoholic fatty liver disease (NAFLD), specifically hepatic steatosis, based on presenting symptoms and diagnostic findings.  Relevant patient history includes [insert relevant history e.g., metabolic syndrome, obesity, type 2 diabetes, dyslipidemia, hypertension] and current medications include [list medications].  Physical examination revealed [insert relevant findings e.g., hepatomegaly or no significant findings].  Liver function tests (LFTs) demonstrated [insert LFT values e.g., mildly elevated ALT and AST, or normal].  Imaging studies, specifically [specify imaging modality e.g., abdominal ultrasound, CT scan, MRI], revealed evidence of fatty infiltration of the liver, consistent with hepatic steatosis.  The patient denies significant alcohol consumption, making alcoholic fatty liver disease less likely.  Diagnosis of liver steatosis was established based on the combination of imaging findings, clinical presentation, and exclusion of other etiologies.  Patient education provided regarding lifestyle modifications, including dietary changes emphasizing a balanced low-fat diet, weight management strategies, and the importance of regular exercise to address the underlying metabolic risk factors.  Follow-up scheduled to monitor disease progression and assess response to lifestyle interventions.  Differential diagnoses considered included [list relevant differentials, e.g., viral hepatitis, autoimmune hepatitis, drug-induced liver injury].  ICD-10 code K76.0 assigned.  Further investigation may be warranted if the patient does not respond to initial management or if liver enzyme levels significantly worsen.  This documentation supports medical necessity for further evaluation and treatment.